股票行情快报：迈得医疗（688310）1月20日主力资金净卖出590.71万元

Core Viewpoint - The company Maide Medical (688310) has shown a modest increase in stock price and a mixed performance in financial metrics, indicating potential growth opportunities alongside some challenges in profitability [1][2]. Group 1: Stock Performance - As of January 20, 2026, Maide Medical's stock closed at 16.26 yuan, with a slight increase of 0.06% [1]. - The trading volume was 34,600 hands, with a total transaction value of 56.879 million yuan [1]. - The net outflow of main funds was 5.9071 million yuan, accounting for 10.39% of the total transaction value, while retail investors saw a net inflow of 5.4365 million yuan, representing 9.56% of the total [1]. Group 2: Financial Performance - For the first three quarters of 2025, Maide Medical reported a main revenue of 225 million yuan, reflecting a year-on-year increase of 2.31% [2]. - The net profit attributable to shareholders was 8.8367 million yuan, up 15.82% year-on-year, while the non-recurring net profit decreased significantly by 526.58% to -1.2785 million yuan [2]. - In Q3 2025 alone, the company achieved a main revenue of 83.643 million yuan, a substantial increase of 54.38% year-on-year, and a net profit of 2.7916 million yuan, which is a remarkable rise of 224.07% [2]. - The company's gross margin stood at 40.19%, with a debt ratio of 29.86% [2].